ST. LOUIS, January 25, 2021 – Cannes Lions selected Anne de Schweinitz, FleishmanHillard’s global managing director, Healthcare, to serve as Pharma Lions Jury President for the 2021 Cannes Lions International Festival of Creativity. This marks the 13th year that FleishmanHillard has been represented on the Cannes Lions jury.
De Schweinitz has long been acknowledged as one of the most influential people in healthcare communications. In 2016, she served on the Pharma Lions Jury and as the Healthcare Jury President for the eurobest Awards. She was initially appointed to lead the Pharma Lions Jury at the 2020 Cannes Lions festival, which was canceled due to the COVID-19 pandemic.
“I’m really curious to look at the types of campaigns and the types of strategies that were employed prior to COVID and now in this interesting world,” said de Schweinitz, who leads an award-winning team of more than 300 global healthcare communications specialists within FleishmanHillard’s Healthcare sector.
De Schweinitz will lead the Pharma Lions jury as it selects the most innovative work that brings science and innovation to life, while aiding in diagnosis, prescription, disease mitigation or illness management for practitioners, patients and targeted consumers. Due to the cancelation of the 2020 festival, the jury will evaluate and award Lions for both 2020 and 2021 campaigns.
Winners will be celebrated at the 2021 Cannes Lions International Festival of Creativity from June 21-25.
Read more about Anne de Schweinitz and the other jury presidents here.